NEW YORK (GenomeWeb) – Horizon Discovery today announced a deal for the marketing of its X-MAN human haploid and diploid isogenic cell line collection by Thermo Fisher Scientific.
Under the supply and commercialization agreement, Thermo Fisher will also further offer Horizon's X-MAN haploid cell line generation service to its worldwide customer base. Thermo Fisher will use its e-commerce and direct sales channels to make the products and services available to the research community.
Financial and other terms were not disclosed.
The X-MAN cell line range is a bank of genetically defined human cell lines that exhibit disease-causing genetics. The models have been highly validated and undergone extensive quality control, Horizon said. The product line includes diploid cell lines and haploid cell lines developed using theCambridge, UK-based firm's proprietary recombinant adeno-associated virus (rAAV) and high-throughput CRISPR gene editing technologies.